HAPA pharm is an internationally operating German company with the focus on the development, production and distribution of cannabinoid containing products.The company stands for a controlled cultivation of cannabis plants in Europe as well as for their own production of suitable products according to GMP guidelines.

Every Satipharm CBD capsule is powered by Gelpell® technology which is clinically proven to increase the bioavailability of CBD. This is based on their clinical trial and the use of Gelpell® Microgel Capsule technology, which was developed and manufactured in Switzerland. By using Satipharm CBD capsules, patients can be confident they will receive the same dose every time.

iX Biopharma launched Xativa™, the world’s first medicinal cannabis sublingual wafer made in Australia and formulated using WaferiX™, their patented sublingual delivery technology. Each wafer contains a nano-emulsion of highly bioavailable broad-spectrum cannabis extract in addition to 30+ terpenes and other beneficial molecules naturally occurring in cannabis.

Australian Natural Therapeutics Group (ANTG) is Australia’s first GACP & GMP accredited medicinal flower cultivation and manufacturing facility. It is Australian grown and made, cultivated in NSW, with all natural, renewable medium, without harmful pesticides. ANTG’s aim is for all Australians to benefit from high-quality, affordable and locally produced medicines.

Little Green Pharma was the first medical cannabis company in Australia to produce locally grown medical-grade cannabis products. Their medicinal cannabis products include a range of oils tested to stringent Australian quality standards. Little Green Pharma also works closely with medical practitioners to assist them with applications for medical cannabis products; saving patients time and money.

Health House currently distributes ZENIVOL™, part of a growing family of proprietary cannabinoid-based medicines produced by ZELIRA Therapeutics. ZELIRA’s customised medicines are uniquely formulated and created by extracting, isolating, and then reassembling the medicinal compounds from the cannabis plant (including cannabinoids and terpenes) to achieve specific and targeted effects.

Ananda Hemp offers high-quality products made with full spectrum CBD oil extracted from 100% Kentucky-grown hemp. Every plant that goes into their high-end line of CBD products is cultivated using organic farming practices. They also contain an array of cannabinoids and hundreds of bioactive phytonutrients from the hemp – resulting in a formula that is truly deserving of the title ‘full spectrum’.

Cronos Australia offers premium quality Australian formulated cannabinoid-based medicines, ensuring a reliable supply chain and affordable pricing to improve patient access. The Adaya range of C02 extracted oral formulations offer patients a range of purified CBD and THC medicines. Cultivated Adaya Whole Flower products are rich in phytocannabinoids and therapeutic terpenoids.

Medigrowth is an Australian medicinal cannabis biotech with multi-disciplinary research involvement spanning plant science & next-gen technologies in biomedical analysis. Medigrowth is driven by a deep passion to improve quality of life for Australian patients. Industry partnership and University-led Australian Research Council Initiatives ensures Medigrowth continues the commitment to development and discovery.

LEVIN is a Melbourne-based medical cannabis company that aspires to develop cannabis-based medicines for patients suffering from chronic pain and other sports related conditions. LEVIN’s mission is to develop medicinal cannabis products backed by clinical evidence. They are committed to developing and providing the best cannabis-based sports medicine possible, made by Australians, for Australians.